Abstract:Computational inference of novel therapeutic values for existing drugs, i.e., drug repositioning, offers the great prospect for faster and low-risk drug development. Previous researches have indicated that chemical structures, target proteins, and side-effects could provide rich information in drug similarity assessment and further disease similarity. However, each single data source is important in its own way and data integration holds the great promise to reposition drug more accurately. Here, we propose a new method for drug repositioning, PreDR (Predict Drug Repositioning), to integrate molecular structure, molecular activity, and phenotype data. Specifically, we characterize drug by profiling in chemical structure, target protein, and side-effects space, and define a kernel function to correlate drugs with diseases. Then we train a support vector machine (SVM) to computationally predict novel drug-disease interactions. PreDR is validated on a well-established drug-disease network with 1,933 interactions among 593 drugs and 313 diseases. By cross-validation, we find that chemical structure, drug target, and side-effects information are all predictive for drug-disease relationships. More experimentally observed drug-disease interactions can be revealed by integrating these three data sources. Comparison with existing methods demonstrates that PreDR is competitive both in accuracy and coverage. Follow-up database search and pathway analysis indicate that our new predictions are worthy of further experimental validation. Particularly several novel predictions are supported by clinical trials databases and this shows the significant prospects of PreDR in future drug treatment. In conclusion, our new method, PreDR, can serve as a useful tool in drug discovery to efficiently identify novel drug-disease interactions. In addition, our heterogeneous data integration framework can be applied to other problems.

Computational drug repositioning: from data to therapeutics.

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review

A Review of Recent Developments and Progress in Computational Drug Repositioning.

Computational Drug Repositioning for Cancer Therapeutics

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds

A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data

A Pathway Profile-Based Method for Drug Repositioning

Review of Drug Repositioning of Computational Approach

Informatics on Drug Repurposing for Breast Cancer.

Turning genome-wide association study findings into opportunities for drug repositioning

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Machine learning for drug repositioning: Recent advances and challenges

Drug Repurposing by Integrated Literature Mining and Drug-Gene-Disease Triangulation

An Analytical Review of Computational Drug Repurposing

Gene Signature-Based Drug Repositioning

Review of Drug Repositioning Approaches and Resources

Drug Repositioning By Kernel-Based Integration Of Molecular Structure, Molecular Activity, And Phenotype Data

System biology approaches for drug repurposing

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines